Regen BioPharma
Founded 2012
About Regen BioPharma
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6.
Company Facts
- Founded: 2012
- Legal name: REGEN BIOPHARMA, INC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Website: regenbiopharmainc.com
- Phone: (619)-722 5505
Social Profiles
Canonical: https://fsome.com/organization/regen-biopharma-8376905 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.